 |
|
Dipeptidyl peptidase-4 inhibitors are associated with improved survival of patients with diabetes mellitus and hepatocellular carcinoma receiving immunotherapy: Letter to the editor on “Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?”
Dorothy Cheuk-Yan Yiu, Huapeng Lin, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Ken Liu, Terry Cheuk-Fung Yip
Clin Mol Hepatol. 2024;30(4):970-973. Published online 2024 Jul 4 DOI: https://doi.org/10.3350/cmh.2024.0280
|
|
Citations to this article as recorded by
 CXCL12 as a Potential Hub Gene for N-Acetylcysteine Treatment of T1DM Liver Disease
Menglong Zhao, Mingzheng Han, Shuaihao Guo, Zhaoxin Tang
Biomolecules.2025; 15(2): 176. CrossRef
|